Does higher usage of low-cost statins correlate with a poorer achievement in cholesterol quality markers for secondary prevention?

There is pressure on primary care trusts, and therefore on GPs, to reach specific levels of use of low-cost statins as a proportion of total statin prescribing. This simple study looks at some markers of the quality of the results achieved. A correlation is found between a higher proportion of low-cost statin prescribing and lower achievement raising questions as to whether financial savings may be offset by poorer results.